CA3305367A1 - Compositions pharmaceutiques comprenant du méloxicam - Google Patents

Compositions pharmaceutiques comprenant du méloxicam

Info

Publication number
CA3305367A1
CA3305367A1 CA3305367A CA3305367A CA3305367A1 CA 3305367 A1 CA3305367 A1 CA 3305367A1 CA 3305367 A CA3305367 A CA 3305367A CA 3305367 A CA3305367 A CA 3305367A CA 3305367 A1 CA3305367 A1 CA 3305367A1
Authority
CA
Canada
Prior art keywords
meloxicam
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3305367A
Other languages
English (en)
Inventor
Herriot Tabuteau
Original Assignee
Axsome Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axsome Therapeutics Inc filed Critical Axsome Therapeutics Inc
Publication of CA3305367A1 publication Critical patent/CA3305367A1/fr
Pending legal-status Critical Current

Links

CA3305367A 2023-09-18 2024-09-17 Compositions pharmaceutiques comprenant du méloxicam Pending CA3305367A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63/583,473 2023-09-18

Publications (1)

Publication Number Publication Date
CA3305367A1 true CA3305367A1 (fr) 2025-03-27

Family

ID=

Similar Documents

Publication Publication Date Title
CA3253043A1 (fr) Compositions pharmaceutiques à base de glp1
EP4230210A4 (fr) Composition pharmaceutique stable
EP4175626A4 (fr) Nouvelles compositions pharmaceutiques
CA3261419A1 (fr) Composition pharmaceutique comprenant de la centanafadine
CA3305367A1 (fr) Compositions pharmaceutiques comprenant du méloxicam
AU2024346246A1 (en) Pharmaceutical compositions comprising meloxicam
CA3303120A1 (fr) Compositions pharmaceutiques comprenant du méloxicam
EP4370117A4 (fr) Compositions pharmaceutiques d'ozanimod
EP4313037A4 (fr) Compositions pharmaceutiques comprenant du zolmitriptan
HK40084389A (en) Pharmaceutical compositions comprising meloxicam
CA3304170A1 (fr) Compositions pharmaceutiques
CA3293008A1 (fr) Compositions pharmaceutiques
HK40130274A (zh) 米尔维仙药物组合物
CA3274331A1 (fr) Compositions pharmaceutiques de milvexian
AU2024217663A1 (en) Milvexian pharmaceutical compositions
HK40112458A (en) Ribociclib pharmaceutical compositions
AU2023901609A0 (en) Pharmaceutical composition
CA3264627A1 (fr) Compositions pharmaceutiques solides d'adagrasib
HK40090022A (en) Pharmaceutical compositions comprising bictegravir
HK40118932A (en) Pharmaceutical composition
HK40096042A (en) Pharmaceutical compositions
HK40112624A (zh) 药物组合物
EP4338730A4 (fr) Composition pharmaceutique
HK40101160A (en) Pharmaceutical composition
HK40065303A (en) Pharmaceutical compositions comprising meloxicam